Boldenone vs Thymosin Beta-4
Moderate Research vs Well Studied
synergistic Mechanism-based · 47% Boldenone and Thymosin Beta-4 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.
Molecular Data
Boldenone Thymosin Beta-4
Weight 286.41 Da (base) 4,963.44 Da
Half-life ~14 days (undecylenate) Dose-dependent; relatively short (exact values not established)
Chain — 43 amino acids
Type 1-dehydrotestosterone steroid (C19H26O2) Thymosin peptide
Key Benefits
Boldenone
01 Lean, quality muscle gains with minimal water retention compared to testosterone
02 Enhanced vascularity through increased red blood cell production and reduced subcutaneous water
03 Significant increase in appetite, supporting caloric surplus during mass-gaining phases
04 Potent stimulation of erythropoiesis, increasing oxygen-carrying capacity and endurance
05 Lower estrogenic activity than testosterone, reducing the need for aromatase inhibitors
06 Lower androgenic side effects (hair loss, acne, prostate stimulation) than testosterone
07 Favorable anabolic-to-androgenic ratio (100:50 compared to testosterone at 100:100)
08 Improved collagen synthesis reported anecdotally, supporting joint and connective tissue health
Thymosin Beta-4
01 Systemic regenerative effects
02 Proven clinical efficacy
03 Optimal bioavailability for tissue repair
04 Promotes angiogenesis
05 Reduces inflammation
Dosing Protocols
Boldenone
200-400 mg/week (moderate) / 1-2x per week (undecylenate)
Lean Bulk - Moderate 200-400 mg/week 1-2x per week (undecylenate)
Performance Enhancement - Standard 400-600 mg/week 2x per week (undecylenate)
Performance Enhancement - High 600-700 mg/week 2x per week (undecylenate)
Boldenone Cypionate Protocol 200-400 mg/week Every 3-4 days
Thymosin Beta-4
2-6mg per injection (varies by protocol and severity) / Daily for acute healing, 2x weekly for maintenance/chronic conditions
Acute Wound Healing 1.6mg Daily
Cardiac Protection 42mg Single dose
Chronic Tissue Repair 6mg Twice weekly
Neurological Recovery 30mg Three times over 72 hours
General Regeneration 2-5mg Daily or every other day
Side Effects
Boldenone
Increased hematocrit and red blood cell count (the primary and most clinically significant side effect, more pronounced than with most other AAS)
Increased appetite (significant and dose-dependent, can be a benefit or hindrance depending on goals)
Anxiety and restlessness ('EQ anxiety' is widely reported anecdotally, particularly at higher doses or in anxiety-prone individuals)
Mild acne and oily skin (less than testosterone due to lower androgenic activity)
Suppression of endogenous testosterone production (profoundly suppressive, as with all AAS)
Mild hair thinning in genetically predisposed individuals (less than testosterone but not absent)
Elevated blood pressure secondary to increased blood volume from erythrocytosis
Increased vascularity (cosmetic effect, but indicative of elevated RBC)
Thymosin Beta-4
Mild injection site reactions
Local inflammation at injection sites
Contraindications
Polycythemia or elevated hematocrit (above 50% at baseline)
Cardiovascular disease, coronary artery disease, or history of thromboembolic events
Hepatic impairment or liver disease
Prostate cancer (active or history of hormone-sensitive prostate cancer)
Pre-existing anxiety disorders (boldenone may significantly exacerbate anxiety symptoms)
Pregnancy or potential for pregnancy (Category X)
Known hypersensitivity to boldenone or any formulation components
Renal impairment (boldenone metabolites are renally cleared)
Active chemotherapy treatment
Severe systemic allergies to peptides
Research Evidence
Boldenone Thymosin Beta-4
Status Moderate Research Well Studied
References 5 studies 4 studies
Latest January 2017 —
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.